RTX is investing significantly in expanding its air defense capacity, with recent commitments including US$100 million for its Portsmouth, Rhode Island facility and an earlier US$53 million for a radar facility in Andover, Massachusetts. These expansions aim to accelerate testing for the U.S. Army and Poland, increase Patriot GEM-T subcomponent output, and enhance missile integration capacity. This strategy is driven by robust global demand for advanced air and missile defense systems, reinforcing RTX's investment narrative of steady growth in revenue and earnings from complex defense systems.

Verizon Communications Inc. announced the final results of its cash tender offers and consent solicitations, repurchasing $1.86 billion in aggregate principal of 20 note series. The offers expired on June 16, 2026, with settlement expected on June 22, 2026. The company also secured requisite consents to amend covenants for several subsidiary debentures.

Lionsgate Studios Corp. (LION) shares saw a pullback after Netflix Inc. (NFLX) denied interest in acquiring the Hollywood studio, despite initial reports suggesting otherwise. The denial led to a slight dip in Lionsgate's stock on Wednesday, following a 14% surge on Tuesday, indicating that investors might not be fully convinced by Netflix's statement. This comes as Netflix has been active in M&A, having previously failed to acquire Warner Bros. Discovery Inc. (WBD) and losing Roku Inc. (ROKU) to Fox Corporation (FOX).

Verizon Communications Inc. announced the expiration and final results of its tender offers and consent solicitations for 20 series of Verizon and its subsidiaries' notes. The company also announced the final results of its separate exchange offers and consent solicitations. Verizon accepted notes with an aggregate principal amount of $1,857,563,000 for purchase, and the requisite consents to effect proposed amendments were received for six series of notes.

Taikang Asset Management Hong Kong Co Ltd increased its stake in Arthur J. Gallagher & Co. by 35.4% in Q4 2025, purchasing 15,608 additional shares to bring its total holdings to $15.45 million. The financial services provider reported better-than-expected quarterly earnings of $4.47 per share, though revenue slightly missed estimates at $4.71 billion, still representing a 29% year-over-year increase. Analysts maintain a "Moderate Buy" rating for the stock with an average price target of $263.71, and the company also declared a quarterly dividend of $0.70 per share.

SailingStone Capital Partners LLC has increased its stake in Williams Companies (NYSE:WMB) by 15.6% in the fourth quarter, bringing their total holdings to 228,624 shares valued at approximately $13.7 million. Despite this institutional buying, several company insiders, including COO Larry C. Larsen and CFO John Dean Porter, have sold substantial amounts of their shares. Williams Companies reported strong Q4 earnings, beating estimates with $0.73 EPS, and analysts maintain a "Buy" rating with a consensus target price of $82.40.

Pfizer is facing renewed scrutiny over its marketing practices, particularly concerning its blockbuster drug Vyndamax. A recent German court ruling ordered Pfizer to cease using the phrase "near complete stabilization" in promotional materials for tafamidis, finding it unsupported by evidence. This incident highlights a recurring challenge for Pfizer, with previous settlements totaling billions of dollars related to illegal drug promotion, raising concerns for investors about the company's compliance culture and long-term credibility.

Titan Wealth CI Ltd recently invested $8.11 million in RTX Corporation, acquiring 44,210 shares, making RTX its 18th largest holding. RTX reported strong Q4 results, beating revenue and EPS estimates, and raised its full-year guidance for 2026. The company also increased its quarterly dividend and maintains a "Moderate Buy" consensus rating from analysts.

The State of Wisconsin Investment Board reduced its holdings in CVS Health Corporation by 4.2% in the fourth quarter, selling 30,135 shares and retaining 680,910 shares worth approximately $54 million. Despite this reduction, institutional ownership in CVS remains high at 80.66%, with several other large investors increasing their positions. Analysts maintain a "Moderate Buy" rating for CVS with an average target price of $100.68, especially after the company surpassed its recent earnings and revenue estimates.

Ibex Wealth Advisors has reduced its stake in AT&T Inc. (NYSE:T) by 8.4% in the fourth quarter, selling 50,364 shares and now holding 552,268 shares valued at $13.7 million. Despite analyst downgrades and price target reductions by some, the overall Wall Street sentiment remains cautiously positive with a "Moderate Buy" consensus and an average price target of $30.55. AT&T's latest earnings surpassed expectations, reporting $0.57 EPS on $31.51 billion in revenue and raising its FY 2026 EPS guidance to $2.25–$2.35, while maintaining a dividend yield of approximately 4.8%.